Financials

  • Market Capitalization 375.39 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2
Fiyat/satışlar oranı
11.96

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3122
IPSC
Century Therapeutics, Inc. - Common Stock
2.13 USD0.00%-7.79%-7.79%+267.24%384.16 M USD
3133
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
12.91 USD-1.53%-10.41%+12.85%+95.90%375.40 M USD
3142
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.70 USD0.00%-4.08%+6.82%+46.42%376.13 M USD
3174
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.62 USD0.00%-6.67%-2.12%+11.06%362.77 M USD

Haberler